Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Subthalamic nucleus and sensorimotor cortex activity during speech production.

Chrabaszcz A, Neumann WJ, Stretcu O, Lipski WJ, Bush A, Dastolfo-Hromack C, Wang D, Crammond DJ, Shaiman S, Dickey MW, Holt LL, Turner RS, Fiez JA, Richardson RM.

J Neurosci. 2019 Jan 30. pii: 2842-18. doi: 10.1523/JNEUROSCI.2842-18.2019. [Epub ahead of print]

PMID:
30700532
2.

Toward Electrophysiology-Based Intelligent Adaptive Deep Brain Stimulation for Movement Disorders.

Neumann WJ, Turner RS, Blankertz B, Mitchell T, Kühn AA, Richardson RM.

Neurotherapeutics. 2019 Jan;16(1):105-118. doi: 10.1007/s13311-018-00705-0. Review.

PMID:
30607748
3.

Local Field Potentials Reflect Dopaminergic and Non-Dopaminergic Activities within the Primate Midbrain.

Pasquereau B, Tremblay L, Turner RS.

Neuroscience. 2019 Feb 10;399:167-183. doi: 10.1016/j.neuroscience.2018.12.016. Epub 2018 Dec 19.

PMID:
30578975
4.

Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.

Souweidane MM, Kramer K, Pandit-Taskar N, Zhou Z, Haque S, Zanzonico P, Carrasquillo JA, Lyashchenko SK, Thakur SB, Donzelli M, Turner RS, Lewis JS, Cheung NV, Larson SM, Dunkel IJ.

Lancet Oncol. 2018 Aug;19(8):1040-1050. doi: 10.1016/S1470-2045(18)30322-X. Epub 2018 Jun 18. Erratum in: Lancet Oncol. 2018 Aug;19(8):e382.

PMID:
29914796
5.

Subthalamic Nucleus Neurons Differentially Encode Early and Late Aspects of Speech Production.

Lipski WJ, Alhourani A, Pirnia T, Jones PW, Dastolfo-Hromack C, Helou LB, Crammond DJ, Shaiman S, Dickey MW, Holt LL, Turner RS, Fiez JA, Richardson RM.

J Neurosci. 2018 Jun 13;38(24):5620-5631. doi: 10.1523/JNEUROSCI.3480-17.2018. Epub 2018 May 22.

6.

Long-Term maintenance of anomia treatment effects in primary progressive aphasia.

Meyer AM, Tippett DC, Turner RS, Friedman RB.

Neuropsychol Rehabil. 2018 Jan 30:1-25. doi: 10.1080/09602011.2018.1425146. [Epub ahead of print]

PMID:
29380657
7.

A selective role for ventromedial subthalamic nucleus in inhibitory control.

Pasquereau B, Turner RS.

Elife. 2017 Dec 4;6. pii: e31627. doi: 10.7554/eLife.31627.

8.

Resveratrol for Alzheimer's disease.

Sawda C, Moussa C, Turner RS.

Ann N Y Acad Sci. 2017 Sep;1403(1):142-149. doi: 10.1111/nyas.13431. Epub 2017 Aug 16. Review.

9.

Dynamics of human subthalamic neuron phase-locking to motor and sensory cortical oscillations during movement.

Lipski WJ, Wozny TA, Alhourani A, Kondylis ED, Turner RS, Crammond DJ, Richardson RM.

J Neurophysiol. 2017 Sep 1;118(3):1472-1487. doi: 10.1152/jn.00964.2016. Epub 2017 Jun 7.

10.

The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive Impairment.

Sacktor N, Soldan A, Grega M, Farrington L, Cai Q, Wang MC, Gottesman RF, Turner RS, Albert M; BIOCARD Research Team.

Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):114-119. doi: 10.1097/WAD.0000000000000194.

11.

Polo-like kinase 2 phosphorylation of amyloid precursor protein regulates activity-dependent amyloidogenic processing.

Lee Y, Lee JS, Lee KJ, Turner RS, Hoe HS, Pak DTS.

Neuropharmacology. 2017 May 1;117:387-400. doi: 10.1016/j.neuropharm.2017.02.027. Epub 2017 Mar 1.

12.

11C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer disease.

Kreisl WC, Lawrence R, Page E, Teich AF, Subramaniam DS, Innis RB, Turner RS.

Neurology. 2017 Mar 7;88(10):1001-1004. doi: 10.1212/WNL.0000000000003693. Epub 2017 Feb 8. No abstract available.

13.

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease.

Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, Turner RS.

J Neuroinflammation. 2017 Jan 3;14(1):1. doi: 10.1186/s12974-016-0779-0.

14.

Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease.

Kreisl WC, Lyoo CH, Liow JS, Snow J, Page E, Jenko KJ, Morse CL, Zoghbi SS, Pike VW, Turner RS, Innis RB.

Neurobiol Aging. 2017 Mar;51:132-140. doi: 10.1016/j.neurobiolaging.2016.12.006. Epub 2016 Dec 16.

15.

An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition.

Turner RS, Chadwick M, Horton WA, Simon GL, Jiang X, Esposito G.

Alzheimers Dement (Amst). 2016 Apr 15;4:1-5. doi: 10.1016/j.dadm.2016.03.009. eCollection 2016.

16.

Chunking as the result of an efficiency computation trade-off.

Ramkumar P, Acuna DE, Berniker M, Grafton ST, Turner RS, Kording KP.

Nat Commun. 2016 Jul 11;7:12176. doi: 10.1038/ncomms12176.

17.

Movement-related dynamics of cortical oscillations in Parkinson's disease and essential tremor.

Kondylis ED, Randazzo MJ, Alhourani A, Lipski WJ, Wozny TA, Pandya Y, Ghuman AS, Turner RS, Crammond DJ, Richardson RM.

Brain. 2016 Aug;139(Pt 8):2211-23. doi: 10.1093/brain/aww144. Epub 2016 Jun 21.

18.

(11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease.

Kreisl WC, Lyoo CH, Liow JS, Wei M, Snow J, Page E, Jenko KJ, Morse CL, Zoghbi SS, Pike VW, Turner RS, Innis RB.

Neurobiol Aging. 2016 Aug;44:53-61. doi: 10.1016/j.neurobiolaging.2016.04.011. Epub 2016 Apr 27.

19.

Hexa (ethylene glycol) derivative of benzothiazole aniline promotes dendritic spine formation through the RasGRF1-Ras dependent pathway.

Lee NJ, Song JM, Cho HJ, Sung YM, Lee T, Chung A, Hong SH, Cifelli JL, Rubinshtein M, Habib LK, Capule CC, Turner RS, Pak DT, Yang J, Hoe HS.

Biochim Biophys Acta. 2016 Feb;1862(2):284-95. doi: 10.1016/j.bbadis.2015.12.007. Epub 2015 Dec 8.

20.

Primary motor cortex of the parkinsonian monkey: altered encoding of active movement.

Pasquereau B, DeLong MR, Turner RS.

Brain. 2016 Jan;139(Pt 1):127-43. doi: 10.1093/brain/awv312. Epub 2015 Oct 21.

21.

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease.

Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, Brewer JB, Rissman RA, Raman R, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2015 Oct 20;85(16):1383-91. doi: 10.1212/WNL.0000000000002035. Epub 2015 Sep 11.

22.

Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer's disease models.

Lonskaya I, Hebron ML, Selby ST, Turner RS, Moussa CE.

Neuroscience. 2015 Sep 24;304:316-27. doi: 10.1016/j.neuroscience.2015.07.070. Epub 2015 Jul 30.

PMID:
26235435
23.

Movement-related discharge in the macaque globus pallidus during high-frequency stimulation of the subthalamic nucleus.

Zimnik AJ, Nora GJ, Desmurget M, Turner RS.

J Neurosci. 2015 Mar 4;35(9):3978-89. doi: 10.1523/JNEUROSCI.4899-14.2015.

24.

Pallidal stimulation suppresses pathological dysrhythmia in the parkinsonian motor cortex.

McCairn KW, Turner RS.

J Neurophysiol. 2015 Apr 1;113(7):2537-48. doi: 10.1152/jn.00701.2014. Epub 2015 Feb 4.

25.

Dopamine neurons encode errors in predicting movement trigger occurrence.

Pasquereau B, Turner RS.

J Neurophysiol. 2015 Feb 15;113(4):1110-23. doi: 10.1152/jn.00401.2014. Epub 2014 Nov 19.

26.

Multifaceted aspects of chunking enable robust algorithms.

Acuna DE, Wymbs NF, Reynolds CA, Picard N, Turner RS, Strick PL, Grafton ST, Kording KP.

J Neurophysiol. 2014 Oct 15;112(8):1849-56. doi: 10.1152/jn.00028.2014. Epub 2014 Jul 30.

27.

Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?

Mandelblatt JS, Stern RA, Luta G, McGuckin M, Clapp JD, Hurria A, Jacobsen PB, Faul LA, Isaacs C, Denduluri N, Gavett B, Traina TA, Johnson P, Silliman RA, Turner RS, Howard D, Van Meter JW, Saykin A, Ahles T.

J Clin Oncol. 2014 Jun 20;32(18):1909-18. doi: 10.1200/JCO.2013.54.2050. Epub 2014 May 19.

28.

Primary motor cortex of the parkinsonian monkey: altered neuronal responses to muscle stretch.

Pasquereau B, Turner RS.

Front Syst Neurosci. 2013 Nov 26;7:98. doi: 10.3389/fnsys.2013.00098. eCollection 2013.

29.

A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease.

Song JM, DiBattista AM, Sung YM, Ahn JM, Turner RS, Yang J, Pak DT, Lee HK, Hoe HS.

Exp Neurol. 2014 Feb;252:105-13. doi: 10.1016/j.expneurol.2013.11.023. Epub 2013 Dec 6.

30.

Axonal and synaptic failure suppress the transfer of firing rate oscillations, synchrony and information during high frequency deep brain stimulation.

Rosenbaum R, Zimnik A, Zheng F, Turner RS, Alzheimer C, Doiron B, Rubin JE.

Neurobiol Dis. 2014 Feb;62:86-99. doi: 10.1016/j.nbd.2013.09.006. Epub 2013 Sep 16.

31.

Movement activation and inhibition in Parkinson's disease: a functional imaging study.

Disbrow EA, Sigvardt KA, Franz EA, Turner RS, Russo KA, Hinkley LB, Herron TJ, Ventura MI, Zhang L, Malhado-Chang N.

J Parkinsons Dis. 2013;3(2):181-92. doi: 10.3233/JPD-130181.

32.

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

Kreisl WC, Lyoo CH, McGwier M, Snow J, Jenko KJ, Kimura N, Corona W, Morse CL, Zoghbi SS, Pike VW, McMahon FJ, Turner RS, Innis RB; Biomarkers Consortium PET Radioligand Project Team.

Brain. 2013 Jul;136(Pt 7):2228-38. doi: 10.1093/brain/awt145. Epub 2013 Jun 17.

33.

A tetra(ethylene glycol) derivative of benzothiazole aniline enhances Ras-mediated spinogenesis.

Megill A, Lee T, DiBattista AM, Song JM, Spitzer MH, Rubinshtein M, Habib LK, Capule CC, Mayer M, Turner RS, Kirkwood A, Yang J, Pak DT, Lee HK, Hoe HS.

J Neurosci. 2013 May 29;33(22):9306-18. doi: 10.1523/JNEUROSCI.1615-12.2013. Erratum in: J Neurosci. 2014 Oct 1;34(40):13567.

34.

Limited encoding of effort by dopamine neurons in a cost-benefit trade-off task.

Pasquereau B, Turner RS.

J Neurosci. 2013 May 8;33(19):8288-300. doi: 10.1523/JNEUROSCI.4619-12.2013.

35.

Sustained reduction of parkinsonian symptoms after "coordinated reset" neuromodulation.

Zwagerman NT, Turner RS, Richardson RM.

Neurosurgery. 2013 Apr;72(4):N22-3. doi: 10.1227/01.neu.0000428427.68620.ad. No abstract available.

PMID:
23511835
36.

Pharmacist-developed sedation protocol and impact on ventilator days.

Hahn L, Beall J, Turner RS, Woolley TW, Hahn M.

J Pharm Pract. 2013 Aug;26(4):406-8. doi: 10.1177/0897190012467209. Epub 2012 Dec 2.

PMID:
23204145
37.

Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease.

Choi SH, Aid S, Caracciolo L, Minami SS, Niikura T, Matsuoka Y, Turner RS, Mattson MP, Bosetti F.

J Neurochem. 2013 Jan;124(1):59-68. doi: 10.1111/jnc.12059. Epub 2012 Nov 21.

38.

Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease.

Sung YM, Lee T, Yoon H, DiBattista AM, Song JM, Sohn Y, Moffat EI, Turner RS, Jung M, Kim J, Hoe HS.

Exp Neurol. 2013 Jan;239:192-201. doi: 10.1016/j.expneurol.2012.10.005. Epub 2012 Oct 11.

39.

Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects.

Rubin JE, McIntyre CC, Turner RS, Wichmann T.

Eur J Neurosci. 2012 Jul;36(2):2213-28. doi: 10.1111/j.1460-9568.2012.08108.x. Review.

40.

Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions.

Farmer JG, Crain BJ, Harris BT, Turner RS.

Neurocase. 2013;19(1):67-75. doi: 10.1080/13554794.2011.654217. Epub 2012 Apr 16.

41.

Testing the contributions of striatal dopamine loss to the genesis of parkinsonian signs.

Franco V, Turner RS.

Neurobiol Dis. 2012 Jul;47(1):114-25. doi: 10.1016/j.nbd.2012.03.028. Epub 2012 Mar 29.

42.

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.

Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM; Alzheimer's Disease Neuroimaging Initiative; Pediatric Imaging, Neurocognition, and Genetics Study, Weiner M, Aisen P, Petersen R, Jack CR Jr, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Mathis C, Cairns NJ, Taylor-Reinwald L, Trojanowki JQ, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Foroud TM, Potkin S, Shen L, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Quinn J, Lind B, Dolen S, Schneider LS, Pawluczyk S, Spann BM, Brewer J, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Ances B, Carroll M, Leon S, Mintun MA, Schneider S, Marson D, Griffith R, Clark D, Grossman H, Mitsis E, Romirowsky A, deToledo-Morrell L, Shah RC, Duara R, Varon D, Roberts P, Albert M, Onyike C, Kielb S, Rusinek H, de Leon MJ, Glodzik L, De Santi S, Doraiswamy PM, Petrella JR, Coleman RE, Arnold SE, Karlawish JH, Wolk D, Smith CD, Jicha G, Hardy P, Lopez OL, Oakley M, Simpson DM, Porsteinsson AP, Goldstein BS, Martin K, Makino KM, Ismail MS, Brand C, Mulnard RA, Thai G, Mc-Adams-Ortiz C, Womack K, Mathews D, Quiceno M, Diaz-Arrastia R, King R, Weiner M, Martin-Cook K, DeVous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Swerdlow RH, Apostolova L, Lu PH, Bartzokis G, Silverman DH, Graff-Radford NR, Parfitt F, Johnson H, Farlow MR, Hake AM, Matthews BR, Herring S, van Dyck CH, Carson RE, MacAvoy MG, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Ging-Yuek, Hsiung R, Feldman H, Mudge B, Assaly M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Mesulam MM, Lipowski K, Wu CK, Johnson N, Sadowsky C, Martinez W, Villena T, Turner RS, Johnson K, Reynolds B, Sperling RA, Johnson KA, Marshall G, Frey M, Yesavage J, Taylor JL, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Kowall N, Killiany R, Budson AE, Norbash A, Johnson PL, Obisesan TO, Wolday S, Bwayo SK, Lerner A, Hudson L, Ogrocki P, Fletcher E, Carmichael O, Olichney J, Kittur S, Borrie M, Lee TY, Bartha R, Johnson S, Asthana S, Carlsson CM, Potkin SG, Preda A, Nguyen D, Tariot P, Fleisher A, Reeder S, Bates V, Capote H, Rainka M, Scharre DW, Kataki M, Zimmerman EA, Celmins D, Brown AD, Pearlson GD, Blank K, Anderson K, Santulli RB, Schwartz ES, Sink KM, Williamson JD, Garg P, Watkins F, Ott BR, Querfurth H, Tremont G, Salloway S, Malloy P, Correia S, Rosen HJ, Miller BL, Mintzer J, Longmire CF, Spicer K, Finger E, Rachinsky I, Drost D, Jernigan T, McCabe C, Grant E, Ernst T, Kuperman J, Chung Y, Murray S, Bloss C, Darst B, Pritchett L, Saito A, Amaral D, DiNino M, Eyngorina B, Sowell E, Houston S, Soderberg L, Kaufmann W, van Zijl P, Rizzo-Busack H, Javid M, Mehta N, Ruberry E, Powers A, Rosen B, Gebhard N, Manigan H, Frazier J, Kennedy D, Yakutis L, Hill M, Gruen J, Bosson-Heenan J, Carlson H.

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3985-90. doi: 10.1073/pnas.1105829109. Epub 2012 Feb 16.

43.

Decreased dendritic spine density and abnormal spine morphology in Fyn knockout mice.

Babus LW, Little EM, Keenoy KE, Minami SS, Chen E, Song JM, Caviness J, Koo SY, Pak DT, Rebeck GW, Turner RS, Hoe HS.

Brain Res. 2011 Sep 30;1415:96-102. doi: 10.1016/j.brainres.2011.07.059. Epub 2011 Aug 5.

44.

ApoE receptor 2 regulates synapse and dendritic spine formation.

Dumanis SB, Cha HJ, Song JM, Trotter JH, Spitzer M, Lee JY, Weeber EJ, Turner RS, Pak DT, Rebeck GW, Hoe HS.

PLoS One. 2011 Feb 15;6(2):e17203. doi: 10.1371/journal.pone.0017203.

45.

Validation of consensus panel diagnosis in dementia.

Gabel MJ, Foster NL, Heidebrink JL, Higdon R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Burke JR, Clark CM, Dekosky ST, Farlow MR, Jagust WJ, Kawas CH, Koeppe RA, Leverenz JB, Lipton AM, Peskind ER, Turner RS, Womack KB, Zamrini EY.

Arch Neurol. 2010 Dec;67(12):1506-12. doi: 10.1001/archneurol.2010.301.

46.

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, DeCarli CS, Jagust WJ, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, DeKosky ST, Farlow MR, Gabel MJ, Higdon R, Kawas CH, Koeppe RA, Lipton AM, Foster NL.

Arch Neurol. 2011 Mar;68(3):329-37. doi: 10.1001/archneurol.2010.295. Epub 2010 Nov 8.

47.

Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons.

Pasquereau B, Turner RS.

Cereb Cortex. 2011 Jun;21(6):1362-78. doi: 10.1093/cercor/bhq217. Epub 2010 Nov 2.

48.

Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease.

Minami SS, Sidahmed E, Aid S, Shimoji M, Niikura T, Mocchetti I, Rebeck GW, Prendergast JS, Dealwis C, Wetzel R, Bosetti F, Matsuoka Y, Hoe HS, Turner RS.

J Neuroinflammation. 2010 Sep 28;7:57. doi: 10.1186/1742-2094-7-57.

49.

Basal ganglia contributions to motor control: a vigorous tutor.

Turner RS, Desmurget M.

Curr Opin Neurobiol. 2010 Dec;20(6):704-16. doi: 10.1016/j.conb.2010.08.022. Epub 2010 Sep 17. Review.

50.

Bursts and oscillations as independent properties of neural activity in the parkinsonian globus pallidus internus.

Chan V, Starr PA, Turner RS.

Neurobiol Dis. 2011 Jan;41(1):2-10. doi: 10.1016/j.nbd.2010.08.012. Epub 2010 Aug 19.

Supplemental Content

Loading ...
Support Center